Anti-Slavery and Human Trafficking Statement

Introduction from the Managing Director

Paramount Medical Solutions is committed to preventing modern slavery, forced labour, servitude, and human trafficking in all areas of our business and supply chains. We recognise our responsibility to operate ethically, transparently, and with integrity, and we expect the same high standards from all organisations and suppliers with whom we work.

As a supplier to the healthcare sector, including public sector procurement frameworks and tender processes, we understand the importance of responsible sourcing, ethical procurement, and the protection of human rights throughout our operations and supply chain activities.

We are committed to promoting equality, fairness, dignity, and respect within our workforce and supply chain, and to ensuring that concerns can be raised openly and without fear of retaliation or recrimination.

Organisation Structure, Business and Supply Chains

Paramount Medical Solutions is a provider of protective clothing and specialist surgical consumables within the healthcare sector. We are headquartered in East Sussex, United Kingdom, and currently employ 5 members of staff.

Our supply chains include surgical materials, plastics, tubing, and packaging sourced from suppliers located in the United Kingdom, Europe, Turkey, China, and India. Paramount Medical Solutions distributes products across the UK and Europe and has an annual turnover of approximately £2,000,000.

We maintain close working relationships with long-standing suppliers while also onboarding new suppliers where necessary to support operational requirements and customer demand.

We recognise that some manufacturing sectors and geographical regions may present an increased risk of labour exploitation and modern slavery. As part of our responsible sourcing approach, we apply proportionate risk management controls within our supplier approval and monitoring processes to help identify and mitigate these risks.

Governance and Accountability

The Managing Director retains overall responsibility for ensuring compliance with the Modern Slavery Act 2015 and for overseeing the effectiveness of Paramount Medical Solutions’ anti-slavery and human trafficking controls.

Responsibility for implementing our policies and supplier compliance processes is shared across management functions involved in procurement, supplier management, and operational oversight.

Our anti-slavery policies and procedures are reviewed annually to ensure they remain proportionate, effective, and aligned with current legislation, procurement requirements, ethical sourcing standards, and evolving supply chain risks.

We are committed to a process of continuous improvement in relation to supply chain transparency, ethical procurement, and modern slavery risk management.

Policies on Slavery and Human Trafficking

Our Anti-Slavery and Human Trafficking Policy outlines our commitment to operating ethically and with integrity in all business relationships. This policy applies to both our internal operations and our supply chain activities and is reviewed annually.

All suppliers are required to comply with our Supplier Code of Conduct and all applicable anti-slavery and human trafficking legislation as part of our supplier onboarding and ongoing supplier management processes.

Our Supplier Code of Conduct sets expectations relating to:

• Labour standards
• Fair working conditions
• Ethical business practices
• Human rights protections
• Compliance with applicable anti-slavery legislation
• Responsible employment practices

We are committed to responsible sourcing practices and promoting transparency throughout our supply chain.

We also maintain whistleblowing and internal reporting arrangements to enable employees and business partners to raise concerns relating to unethical conduct, labour exploitation, or potential modern slavery risks.

Due Diligence Processes

We operate a risk-based approach to supplier due diligence designed to identify and mitigate the risk of modern slavery within our operations and supply chain.

Our supplier due diligence procedures may include:

• Supplier vetting during onboarding
• Review of supplier compliance information
• Supplier acknowledgement of our Supplier Code of Conduct
• Ongoing supplier engagement
• Monitoring of publicly available risk indicators
• Assessment of suppliers operating in higher-risk regions
• Review of supplier ethical and labour standards where appropriate

We use publicly available resources, including information from organisations such as the Global Slavery Index, to help identify elevated risk areas within our supply chain.

Enhanced scrutiny is applied to suppliers operating in regions identified as presenting a higher risk of modern slavery, including China, Turkey, and India.

As an SME business, we recognise that supply chain oversight beyond direct suppliers can present challenges. However, we remain committed to improving visibility within our supply chain and strengthening our due diligence processes over time.

Risk Areas and Risk Management

We recognise that certain parts of our supply chain, particularly suppliers operating within higher-risk geographical regions and manufacturing sectors, may present an increased risk of modern slavery and labour exploitation.

To manage these risks, Paramount Medical Solutions has implemented the following measures:

• Supplier vetting and approval procedures
• Supply chain mapping to identify higher-risk areas
• Supplier compliance requirements through our Supplier Code of Conduct
• Ongoing monitoring of supply chain risks and ethical sourcing considerations
• Internal reporting and whistleblowing arrangements
• Review of supplier relationships and sourcing practices where elevated risks are identified

Our approach is based on proportionate and risk-based management controls appropriate to the size and structure of our business.

Where potential concerns or non-compliance issues are identified, Paramount Medical Solutions will work collaboratively with suppliers to implement appropriate corrective actions within agreed timeframes.

Where suppliers fail to demonstrate satisfactory improvement or compliance with our ethical standards, we reserve the right to suspend or terminate the business relationship.

Effectiveness and Key Performance Indicators (KPIs)

We monitor the effectiveness of our anti-slavery programme through proportionate performance measures appropriate to the size and structure of our business.

These measures include:

• 100% of employees completing modern slavery awareness training
• 100% of new key suppliers being required to comply with our Supplier Code of Conduct and applicable anti-slavery legislation
• Ongoing identification and review of suppliers operating within higher-risk regions
• Maintenance of whistleblowing and reporting procedures
• Annual review of anti-slavery policies and procedures
• Ongoing review of supplier-related ethical sourcing risks

During the reporting period, no concerns relating to modern slavery or human trafficking were identified or reported through our internal reporting processes.

Training and Awareness

Modern slavery awareness forms part of our employee onboarding and ongoing training programme.

All employees are required to complete modern slavery awareness training, with refresher training provided periodically to maintain awareness of:

• Modern slavery risks
• Indicators of forced labour and exploitation
• Reporting responsibilities
• Ethical sourcing expectations
• Supplier risk awareness

We also encourage suppliers to promote awareness and training within their own organisations to support broader understanding of modern slavery risks throughout the supply chain.

Future Steps

During 2026, Paramount Medical Solutions will continue to strengthen its modern slavery controls by:

• Expanding supplier due diligence activities across key supply chain partners
• Increasing visibility of tier-2 suppliers within higher-risk regions
• Conducting targeted supplier compliance reviews where elevated risks are identified
• Reviewing supplier contractual requirements to further strengthen ethical sourcing obligations
• Continuing annual staff training and awareness programmes
• Continuing to improve supply chain transparency and responsible sourcing practices
• Further embedding ethical procurement considerations into supplier management activities

Approval

This statement is made pursuant to section 54(1) of the Modern Slavery Act 2015 and constitutes Paramount Medical Solutions Limited’s Anti-Slavery and Human Trafficking Statement for the financial year ending 31 December 2025.

This statement has been approved by the Board of Directors and will be reviewed annually.

Rolf Sandor

Managing Director
Paramount Medical Solutions Limited
21 May 2026